经皮质入路岛叶胶质瘤切除:临床结局与预测因素
研究纳入255例连续经皮质入路切除岛叶胶质瘤的病例,分析肿瘤位置(Berger-Sinai分型)、切除程度、术后神经功能结局与总生存。低级别胶质瘤占63.14%,巨大型肿瘤占58.82%;低级别胶质瘤中肿瘤位置是生存的独立预测因素(p=0.003),切除程度与低级别(p=0.001)和高级别(p=0.008)胶质瘤患者的生存相关。结论认为经皮质入路可在所有岛叶区域实现最大程度肿瘤切除,联合多模态影像与皮质及皮质下功能区定位有利于术后神经功能结局并延长患者生存。
要点
- 低级别胶质瘤中肿瘤位置是生存独立预测因素(p=0.003),巨大型肿瘤生存最短(p=0.003)。
- 切除程度与低级别(p=0.001)和高级别(p=0.008)胶质瘤患者生存相关。
- 术后一过性神经功能缺损占12.79%,永久性缺损占15.70%,出现任一缺损者生存更差(p<0.001)。
核心结论
- 经皮质手术入路可在所有岛叶区域实现最大程度肿瘤切除。
- 将多模态脑影像及皮质与皮质下功能区定位等辅助技术纳入经皮质入路,有利于术后神经功能结局并延长患者生存。
研究设计与样本
- 研究为本中心255例连续接受经皮质肿瘤切除的岛叶胶质瘤病例分析。
- 分析纳入肿瘤分子病理、基于Berger-Sinai分型的肿瘤位置、切除程度、各岛叶区域术后神经功能结局及相应总生存。
主要发现
- 低级别岛叶胶质瘤更常见(63.14%)。
- 巨大型肿瘤(累及所有岛叶区域)最常见(58.82%),其次为区I+IV(前部)肿瘤(20.39%)。
- 低级别胶质瘤中肿瘤位置是生存的独立预测因素(p=0.003),巨大型肿瘤患者生存最短(p=0.003)。
- 异柠檬酸脱氢酶1(IDH1)突变与巨大型肿瘤的关联较位于某一区域区的局灶性肿瘤更常见(p<0.001)。
- 切除程度与低级别胶质瘤(p=0.001)和高级别胶质瘤(p=0.008)患者生存相关。
关键数值与推荐
- 巨大型肿瘤患者更易出现术后神经功能缺损(p=0.038)。
- 术后一过性神经功能缺损记录于12.79%的患者,永久性缺损记录于15.70%的患者。
- 出现一过性或永久性术后神经功能缺损的患者生存更差(p<0.001)。
临床怎么用
- 原文结论认为经皮质入路可在所有岛叶区域实现最大程度肿瘤切除。
- 原文结论认为将多模态脑影像及皮质与皮质下功能区定位等辅助技术纳入经皮质入路,有利于术后神经功能结局并延长患者生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Insular lobe gliomas continue to challenge neurosurgeons due to their complex anatomical position. Transcortical and transsylvian corridors remain the primary approaches for reaching the insula, but the adoption of one technique over the other remains controversial. The authors analyzed the transcortical approach of resecting insular gliomas in the context of patient tumor location based on the Berger-Sinai classification, achievable extents of resection (EORs), overall survival (OS), and postsurgical neurological outcome. METHODS: The authors studied 255 consecutive cases of insular gliomas that underwent transcortical tumor resection in their division. Tumor molecular pathology, location, EOR, postoperative neurological outcome for each insular zone, and the accompanying OS were incorporated into the analysis to determine the value of this surgical approach. RESULTS: Lower-grade insular gliomas (LGGs) were more prevalent (63.14%). Regarding location, giant tumors (involving all insular zones) were most prevalent (58.82%) followed by zone I+IV (anterior) tumors (20.39%). In LGGs, tumor location was an independent predictor of survival (p = 0.003), with giant tumors demonstrating shortest patient survival (p = 0.003). Isocitrate dehydrogenase 1 (IDH1) mutation was more likely to be associated with giant tumors (p < 0.001) than focal tumors located in a regional zone. EOR correlated with survival in both LGG (p = 0.001) and higher-grade glioma (HGG) patients (p = 0.008). The highest EORs were achieved in anterior-zone LGGs (p = 0.024). In terms of developing postoperative neurological deficits, patients with giant tumors were more susceptible (p = 0.038). Postoperative transient neurological deficit was recorded in 12.79%, and permanent deficit in 15.70% of patients. Patients who developed either transient or permanent postsurgical neurological deficits exhibited poorer survival (p < 0.001). CONCLUSIONS: The transcortical surgical approach can achieve maximal tumor resection in all insular zones. In addition, the incorporation of adjunct technologies such as multimodal brain imaging and mapping of cortical and subcortical eloquent brain regions into the transcortical approach favors postoperative neurological outcomes, and prolongs patient survival.
引用
- Hameed NUF, Qiu T, Zhuang D, et al. Transcortical insular glioma resection: clinical outcome and predictors. J Neurosurg. 2018. PMID: 30485243. doi:10.3171/2018.4.JNS18424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。